110 related articles for article (PubMed ID: 7862705)
1. Social interactions in rats: behavioral and neurochemical alterations in DSP-4-treated rats.
Zagrodzka J; Wieczorek M; Romaniuk A
Pharmacol Biochem Behav; 1994 Nov; 49(3):541-8. PubMed ID: 7862705
[TBL] [Abstract][Full Text] [Related]
2. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
3. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
[TBL] [Abstract][Full Text] [Related]
4. Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.
Weinshenker D; Ferrucci M; Busceti CL; Biagioni F; Lazzeri G; Liles LC; Lenzi P; Pasquali L; Murri L; Paparelli A; Fornai F
J Neurochem; 2008 Apr; 105(2):471-83. PubMed ID: 18042179
[TBL] [Abstract][Full Text] [Related]
5. Pretraining infusion of DSP-4 into the amygdala impaired retention in the inhibitory avoidance task: involvement of norepinephrine but not serotonin in memory facilitation.
Liang KC
Chin J Physiol; 1998 Dec; 41(4):223-33. PubMed ID: 10099870
[TBL] [Abstract][Full Text] [Related]
6. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.
Introini IB; Baratti CM; Huygens P
Psychopharmacology (Berl); 1984; 82(1-2):107-12. PubMed ID: 6420819
[TBL] [Abstract][Full Text] [Related]
7. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.
Hughes ZA; Stanford SC
Psychopharmacology (Berl); 1998 Apr; 136(3):299-303. PubMed ID: 9566816
[TBL] [Abstract][Full Text] [Related]
8. Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats).
Petkov VD; Stancheva SL; Tocuschieva L; Petkov VV
Gen Pharmacol; 1990; 21(1):71-5. PubMed ID: 2105261
[TBL] [Abstract][Full Text] [Related]
9. Bicuculline administration into ventromedial hypothalamus: effects on fear and regional brain monoamines and GABA concentrations in rats.
Zagrodzka J; Romaniuk A; Wieczorek M; Boguszewski P
Acta Neurobiol Exp (Wars); 2000; 60(3):333-43. PubMed ID: 11016075
[TBL] [Abstract][Full Text] [Related]
10. DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
Riekkinen P; Riekkinen M; Valjakka A; Riekkinen P; Sirviö J
Brain Res; 1992 Jan; 570(1-2):293-9. PubMed ID: 1617419
[TBL] [Abstract][Full Text] [Related]
11. Effects of DSP-4 on monoamine and monoamine metabolite levels and on beta adrenoceptor binding kinetics in rat brain at different times after administration.
Theron CN; de Villiers AS; Taljaard JJ
Neurochem Res; 1993 Dec; 18(12):1321-7. PubMed ID: 7505893
[TBL] [Abstract][Full Text] [Related]
12. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.
Cassano T; Gaetani S; Morgese MG; Macheda T; Laconca L; Dipasquale P; Taltavull J; Shippenberg TS; Cuomo V; Gobbi G
Neurochem Res; 2009 Aug; 34(8):1417-26. PubMed ID: 19229609
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
Bromek E; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
[TBL] [Abstract][Full Text] [Related]
14. Central DSP-4 treatment decreases norepinephrine levels and courtship behavior in male zebra finches.
Barclay SR; Harding CF; Waterman SA
Pharmacol Biochem Behav; 1996 Jan; 53(1):213-20. PubMed ID: 8848453
[TBL] [Abstract][Full Text] [Related]
15. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins.
Dailly E; Chenu F; Petit-Demoulière B; Bourin M
J Neurosci Methods; 2006 Jan; 150(1):111-5. PubMed ID: 16098600
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical alterations evoked by p-Chlorophenylalanine application in rats examined in the light-dark crossing test.
Koprowska M; Krotewicz M; Romaniuk A; Strzelczuk M; Wieczorek M
Acta Neurobiol Exp (Wars); 1999; 59(1):15-22. PubMed ID: 10230072
[TBL] [Abstract][Full Text] [Related]
17. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
18. Effect of noradrenergic denervation by neonatal DSP-4 on peptide neurotransmitter systems in the rat brain.
Donnerer J; Humpel C; Saria A
Neuropeptides; 1992 Jun; 22(2):103-6. PubMed ID: 1357578
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
[TBL] [Abstract][Full Text] [Related]
20. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze.
Lapiz MD; Mateo Y; Durkin S; Parker T; Marsden CA
Psychopharmacology (Berl); 2001 May; 155(3):251-9. PubMed ID: 11432687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
